Without a doubt, this week will be as it gets to likely determine the trajectory of the markets for the rest of the quarter and perhaps the rest of the year. While the naïve course of action is to focus on fourth quarter and full-year 2018 results, smart eyes will be on guidance. After all; […]
It is getting real nasty out there for the stock market. Biotech, growth and tech stocks which led the market rally are getting taken out one by one and getting shot between the eyes. There is plenty occurring below the surface which is likely contributing to the market weakness and volatility. To the casual observer […]
This week is the heart of 2nd quarter earnings season. Roughly 16% of the companies in the Standard & Poor’s 500 (SPX) will report their results this week. Here is a taste of what’s on the menu for the week: Monday – Alphabet (GOOGL) Tuesday – AT&T (T), Verizon (VZ), 3M (MMM) Wednesday – Boeing […]
While earnings season is not over, it hit its apex Tuesday when Apple reported quarterly results. The stock has been in retreat since mid-March on fears that the company would suffer from a decline in iPhone sales. Well, as it turns out, despite some mild disappointment in iPhone sales, versus consensus estimates, the company managed […]
After a tumultuous first quarter, one would have expected a somewhat subdued second quarter. As we learned just after a week of trading in April, you can throw that expectation out the window. We must get accustomed to a higher level of realized market volatility. One word of advice – don’t take your investment cues […]
So far, this week; we had Apple’s (AAPL) earnings, Facebook’s (FB) earnings, an FOMC meeting and the healthcare vote in the House of Representatives. AAPL earnings were met with little fanfare. AAPL declined just 0.31% the day after its earnings release. FB declined 0.63% the day after its earnings. Then there was the FOMC basically […]
Equity markets gapped lower at the market open. Most media outlets attributed this as a reaction to the travel bans imposed by President Trump. That sounded pithy (or as Woody Allen wrote “it had great pith”) but it was indeed not the case. The fact is that after a huge run since the Election, the […]
I hope you had a restful and enjoyable holiday weekend. I needed the rest because I caught a nasty bug which had me down for the count for a few days. Of course, those four exciting NFL playoff games helped the recuperation process. I am back to my normal investing / trading condition and look […]
October has been torture for investors, but the real damage is not in the headline Standard & Poor’s 500 (SPX) index but below the surface. For example, SPX has declined 1.62% in October, whereas the widely held biotech ETF, VanEck Vectors (BBH) has declined 7.66%; the SPDRs Consumer Discretionary ETF (XLH) declined 2.27%; the SPDRs Materials […]
Alcoa (AA) officially opened earnings season with what was considered a disappointing report. One must understand that Alcoa is about to spit into two companies, so the earnings report really offered little or no investment value. With a slow boring market, traders needed something to bet on so Alcoa was the cockroach of the day. […]
